4-Carboxyphenylboronic Acid → 4'-(5-Methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxylic acid

HRID 1741089

반응식

HRID 1741089 반응식
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([CH3:13])=[N:11][N:12]=2)=[CH:4][CH:3]=1.B([C:17]1[CH:25]=[CH:24][C:20]([C:21]([OH:23])=[O:22])=[CH:19][CH:18]=1)(O)O>>[CH3:13][C:10]1[O:9][C:8]([C:5]2[CH:6]=[CH:7][C:2]([C:17]3[CH:25]=[CH:24][C:20]([C:21]([OH:23])=[O:22])=[CH:19][CH:18]=3)=[CH:3][CH:4]=2)=[N:12][N:11]=1

참가 물질

3

실험 절차

The title compound was prepared from a stirred solution of 2-(4-bromophenyl)-5-methyl-1,3,4-oxadiazole (D110) and 4-boronobenzoic acid using a similar procedure to Description 11, as a white crystalline solid (68%).

출처 및 근거

ORD 기록
ord-dbeddab85e2341fb9b9e6daa6a85c833
출처 데이터셋
uspto-grants-1999_10
특허 번호
US05972951

연결된 노트

불러오는 중…